Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Busch

Showing results (611-620 of 678) with videos related to

Pageof 68
Sort By:
Annals of Surgical Oncology|April 26, 2022
Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic CancerThijs J Schouten, Lois A Daamen, Galina Dorland, et al.
Annals of Surgical Oncology|March 14, 2018
Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort StudySjors Klompmaker, Jony van Hilst, Sarah L Gerritsen, et al.
Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2025
Endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction (ENDURO): a randomised controlled trialYorick L van de Pavert, Janine B Kastelijn, Marc G Besselink, et al.
Annals of Surgery|July 21, 2023
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter StudyLeonard W F Seelen, Deesje Doppenberg, Thomas F Stoop, et al.
The Lancet. Oncology|March 7, 2018
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable diseaseEmil Ter Veer, L Bengt van Rijssen, Marc G Besselink, et al.
Annals of Surgical Oncology|June 27, 2024
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide StudyI W J M van Goor, P C M Andel, F S Buijs, et al.
Trials|June 20, 2024
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Trials|July 5, 2024
Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
The Lancet. Gastroenterology & Hepatology|February 9, 2026
Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trialThijs J Schouten, Kyra J Prinsze, Anne Claire Henry, et al.
Pageof 68

Showing results (611-620 of 678) with videos related to

Sort By:
Pageof 68
Annals of Surgical Oncology|April 26, 2022
Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic CancerThijs J Schouten, Lois A Daamen, Galina Dorland, et al.
Annals of Surgical Oncology|March 14, 2018
Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort StudySjors Klompmaker, Jony van Hilst, Sarah L Gerritsen, et al.
Annals of Surgical Oncology|November 7, 2025
Impact of Different Primary Treatment Strategies on Recurrence-Focused Treatment of Pancreatic Ductal AdenocarcinomaPaul C M Andel, Iris W J M van Goor, Thijs J Schouten, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2025
Endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction (ENDURO): a randomised controlled trialYorick L van de Pavert, Janine B Kastelijn, Marc G Besselink, et al.
Annals of Surgery|July 21, 2023
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter StudyLeonard W F Seelen, Deesje Doppenberg, Thomas F Stoop, et al.
The Lancet. Oncology|March 7, 2018
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable diseaseEmil Ter Veer, L Bengt van Rijssen, Marc G Besselink, et al.
Annals of Surgical Oncology|June 27, 2024
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide StudyI W J M van Goor, P C M Andel, F S Buijs, et al.
Trials|June 20, 2024
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
Trials|July 5, 2024
Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts designL A Daamen, I W J M van Goor, V P Groot, et al.
The Lancet. Gastroenterology & Hepatology|February 9, 2026
Long-term oncological outcomes following algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection: a post-hoc analysis of a nationwide, stepped-wedge cluster-randomised trialThijs J Schouten, Kyra J Prinsze, Anne Claire Henry, et al.
Pageof 68